RedCo II Master Fund, L.P. insider trades
RedCo II Master Fund, L.P. has filed 4 Form 4s with the SEC that we hold, for ADC Therapeutics SA (ADCT) (10% owner) and AUGX (Director, 10% owner). Across all of them we count 2 purchases worth $4.1M and 7 sales worth $19.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 6 sales ($19.6M). The largest single trade was a sale of 2,634,506 shares of ADC Therapeutics SA worth $8.6M, dated 2026-04-02. The first filing on our record is dated 2023-11-22 and the latest 2026-04-02.
ADC Therapeutics SA (ADCT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-07-01 | P, purchase reported on Form 4 | 400,000 | $1.1M | 2024-07-03 |
| 2024-12-04 | S, sale reported on Form 4 | 25,352 | $52.5K | 2024-12-06 |
| 2026-03-31 | S, sale reported on Form 4 | 196,229 | $735.9K | 2026-04-02 |
| 2026-03-31 | S, sale reported on Form 4 | 188,407 | $706.5K | 2026-04-02 |
| 2026-04-01 | S, sale reported on Form 4 | 162,517 | $617.6K | 2026-04-02 |
| 2026-04-01 | S, sale reported on Form 4 | 169,265 | $643.2K | 2026-04-02 |
| 2026-04-02 | S, sale reported on Form 4 | 2,634,506 | $8.6M | 2026-04-02 |
| 2026-04-02 | S, sale reported on Form 4 | 2,529,491 | $8.3M | 2026-04-02 |
AUGX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-11-20 | P, purchase reported on Form 4 | 750,000 | $3.0M | 2023-11-22 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1921783) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms